2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stellate Ganglion Block With Lidocaine for the Treatment of COVID-19-Induced Parosmia Stellate Ganglion Block, Placebo - Parosmia | Phase 3 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 44 | 2024-02-15 | 2024-10-23 |
| Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia intranasal spray ivermectin - Anosmia | Phase 2 / Phase 3 | Unknown | South Valley University | 117 | 2021-04-20 | 2022-04-22 |
Anosmia (2) · Post-Acute COVID-19 Syndrome (1)
Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Sensation Disorders (2) · Signs and Symptoms (2) · COVID-19 (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pathologic Processes (1)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · South Valley University (1)
Canada (1) · Egypt (1)
PMID 15023839, PMID 23875929, PMID 33320115, PMID 33453291, PMID 34792577, PMID 34830550, PMID 34870334, PMID 35065619, PMID 35320821, PMID 35389456, PMID 36164334